Device Trial Radar · NCT07949240
Epidural Spinal Cord Stimulation for Motor Recovery After Spinal Cord Injury: A Pilot Study
Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
10
Planned (sponsor's estimate)
Start
May 1, 2027
Primary completion
Dec 1, 2028
Study completion Dec 1, 2028
Sponsor
- Lead sponsor
- Dr. Gabriel ZeiligGovernment (non-federal)
- Sponsor type
- Government (non-federal)
- First posted
- Nov 19, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This pilot study aims to evaluate the safety and feasibility of epidural spinal cord stimulation (scES) combined with intensive rehabilitation in individuals with chronic spinal cord injury (SCI). The study will enroll up to 10 adults with spinal cord injury who are unable to walk independently in the community. Participants will undergo surgical implantation of an epidural spinal cord stimulation system, followed by individualized stimulation programming and 80 sessions of activity-based rehabilitation focusing on voluntary lower extremity movements, standing, and stepping. The primary objectives are to assess the safety of the implantation and stimulation procedures and the feasibility of implementing the rehabilitation protocol. Secondary objectives include evaluating potential changes in motor function, autonomic function, psychological well-being, and quality of life. Participants will be followed for approximately 12 months, with repeated clinical and functional assessments throughout the study.
Conditions
- Spinal Cord Injuries (Complete and Incomplete)
Interventions
Epidural Spinal Cord Stimulation (scES)Device
Surgical implantation of a Medtronic Specify 5-6-5 epidural electrode array over the lumbosacral spinal cord and a Medtronic Intellis implantable pulse generator. Stimulation will be individually programmed using the StimX research system. Electrode configurations and stimulation parameters will be optimized through neurophysiological mapping to facilitate voluntary lower extremity movements, standing, and stepping.
Activity-Based Rehabilitation (ABT)Other
Individualized, task-specific rehabilitation combined with epidural spinal cord stimulation. Training will include voluntary lower extremity movements, standing, stepping, sit-to-stand practice, transfers, and other functional tasks. Participants will complete 80 training sessions over approximately 3-6 months, generally five sessions per week, with approximately one hour of active training per session.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Serious Adverse EventsTime frame: From implantation through 12 months after implantation.
- Participant Recruitment RateTime frame: During the recruitment period (anticipated up to 12 months).
- Retention at 6 MonthsTime frame: 6 months after implantation.
3 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Sheba Medical Center
Ramat Gan, Israel
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.